Schonfeld Strategic Advisors’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.4K | Sell |
14,343
-8,500
| -37% | -$14.5K | ﹤0.01% | 1826 |
|
|
2025
Q1 | $36.1K | Sell |
22,843
-26,000
| -53% | -$41.1K | ﹤0.01% | 1951 |
|
|
2024
Q4 | $87.4K | Sell |
48,843
-229,157
| -82% | -$410K | ﹤0.01% | 1779 |
|
|
2024
Q3 | $1.68M | Sell |
278,000
-37,736
| -12% | -$229K | 0.01% | 833 |
|
|
2024
Q2 | $1.66M | Sell |
315,736
-52,764
| -14% | -$278K | 0.01% | 872 |
|
|
2024
Q1 | $3.13M | Buy |
+368,500
| New | +$3.13M | 0.02% | 678 |
|
|
2021
Q4 | – | Sell |
-10,600
| Closed | -$85K | – | 2074 |
|
|
2021
Q3 | $85K | Sell |
10,600
-76,456
| -88% | -$613K | ﹤0.01% | 1875 |
|
|
2021
Q2 | $2.49M | Sell |
87,056
-15,100
| -15% | -$431K | 0.03% | 619 |
|
|
2021
Q1 | $2.97M | Buy |
+102,156
| New | +$2.97M | 0.04% | 538 |
|